AtriCure, Inc.

ATRC Healthcare Medical Instruments & Supplies

AtriCure, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $534.5 million, up 14.9% from fiscal 2024.

Revenue
+15.0%
EPS
+1,583.9%
Free cash flow
−0.73%
Total debt
−17.3%

Quarter to September 2026, against a year earlier

60.70 4.83 −7.37%
Market cap
$3.1B
P/E
199×
Fwd P/E
573×
Dividend yield
—
F-score
7/9
Altman Z
7.31
Beneish M
−2.91
Dividend safety
n/a

AtriCure, Inc. (ATRC) Free cash flow

Alert me on Free cash flow

AtriCure, Inc.'s free cash flow for fiscal 2025 was $48.3M, up 6,170.6% from $770.0K in fiscal 2024. Over the twelve months to 30 September 2026 it was $52.9M. Over the past ten years it has ranged from −$39.0M (fiscal 2022) to $48.3M (fiscal 2025) — the current reading is the highest in ten years. Free cash flow has risen for 3 consecutive fiscal years. AtriCure, Inc. ranks 21st of 51 Medical Instruments & Supplies companies by free cash flow.

Free cash flow, annual

Embed this chart

Annual newest first

Period Free cash flow Change
FY2025 $48.3M 6,170.65%
FY2024 $770.0K —
FY2023 −$7.5M —
FY2022 −$39.0M —
FY2021 −$23.5M —
FY2020 −$25.1M —
FY2019 −$28.0M —
FY2018 −$10.4M —
FY2017 −$15.3M —
FY2016 −$22.8M —

Quarterly newest first

Period Free cash flow Change
Sep 2026 $23.9M 29.89%
Jun 2026 $18.4M —
Mar 2026 −$7.8M —
Dec 2025 $18.4M (23.58%)
43 more quarters

Against its own ten years

Low −$39.0M High $48.3M
Ten-year median −$22.8M
Current reading's percentile 100

Free cash flow against peers

What Free cash flow is

Free Cash Flow tells an investor how much cash a company’s operations generate after paying for its investment in physical and intangible assets.

Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)

The full definition of Free cash flow →

More on ATRC